NASDAQ: BCABBioatla Inc Stock Ownership - Who owns Bioatla?
Insider buying vs selling
Have Bioatla Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Scott Andrew Smith | Director | 2024-03-31 | 2,181 | $3.44 | $7.50kSell |
| Eric Sievers | Chief Medical Officer | 2024-03-31 | 572 | $3.44 | $1.97kSell |
| Eric Sievers | Chief Medical Officer | 2024-02-29 | 572 | $2.70 | $1.54kSell |
| Scott Andrew Smith | Director | 2024-02-29 | 2,181 | $2.70 | $5.89kSell |
| Eric Sievers | Chief Medical Officer | 2024-01-31 | 657 | $1.92 | $1.26kSell |
| Scott Andrew Smith | Director | 2024-01-31 | 2,181 | $1.92 | $4.19kSell |
| Eric Sievers | Chief Medical Officer | 2023-12-31 | 555 | $2.46 | $1.37kSell |
| Scott Andrew Smith | Director | 2023-12-31 | 1,791 | $2.46 | $4.41kSell |
| Sylvia McBrinn | Director | 2023-12-26 | 4,000 | $2.33 | $9.32kBuy |
| Jay M. Phd Short | Chief Executive Officer | 2023-12-20 | 50,000 | $2.14 | $106.90kBuy |
BCAB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BCAB insiders and whales buy or sell their stock.
BCAB Shareholders
What type of owners hold Bioatla Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Carolyn Anderson Short | 14.40% | 6,927,741 | $15.52M | Insider |
| Soleus Capital Management LP | 8.45% | 4,065,197 | $9.11M | Institution |
| Jay M. Phd Short | 7.21% | 3,469,658 | $7.77M | Insider |
| Blackrock Inc | 6.00% | 2,884,014 | $6.46M | Institution |
| Tang Capital Management LLC | 5.25% | 2,524,076 | $5.65M | Institution |
| Cormorant Asset Management LP | 4.77% | 2,292,060 | $5.13M | Insider |
| Pfizer Inc | 4.65% | 2,238,090 | $5.01M | Insider |
| Vanguard Group Inc | 4.33% | 2,081,370 | $4.66M | Institution |
| Morgan Stanley | 3.98% | 1,913,115 | $4.29M | Institution |
| Cormorant Asset Management LP | 2.46% | 1,181,115 | $2.65M | Institution |
BCAB vs Biotech Stocks
Bioatla Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.